Friess Associates’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding QGEN
HJGA
FCM
Friess Associates's QGEN Position: Q4 2018 in Review
Friess Associates sold out of Qiagen (QGEN) in Q4 2018, closing a stake of 501,611 shares — an estimated $20.1M sold.
Friess Associates first reported a position in QGEN in Q2 2018 and held it in 2 quarters. The position peaked at $20.1M in Q3 2018. 251 funds tracked by Wall St. Rank hold QGEN as of Q4 2018.
- Friess Associates reported no remaining Qiagen position as of Q4 2018 after selling out during the quarter.
- Friess Associates sold 501,611 Qiagen shares in Q4 2018, an estimated $20.1M.
- Friess Associates first reported a position in Qiagen in Q2 2018 and held it in 2 quarters.
- Friess Associates's Qiagen position peaked at $20.1M in Q3 2018.
- 251 funds tracked by Wall St. Rank held Qiagen as of Q4 2018.
Based on Friess Associates's 13F filing for Q4 2018, filed 14 Feb 2019.